INSIGHT-Drugmaker Mylan gets boost from unlikely source: coal
June 21, 2017 at 01:00 AM EDT
NEW YORK, June 21 (Reuters) - Mylan N.V. is best known for producing EpiPen emergency allergy treatments and generic drugs.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.